NDC11 17772013360
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 17772-0133-60 | 17772-0133 |
| 17772-133-60 | 17772-133 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| QELBREE | VILOXAZINE HYDROCHLORIDE | Supernus Pharmaceuticals, Inc | aedf408d-0f84-418d-9416-7c39ddb0d29a | 2026-10-05 | Boxed warning, Warnings, Adverse reactions | 17772-133-60 17772-133 17772013360 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.